Literature DB >> 16253896

Midgut carcinoid tumours: surgical treatment and prognosis.

Göran Kerström1, Per Hellman, Ola Hessman.   

Abstract

Midgut carcinoids originating in the small intestine are the most common cause of the carcinoid syndrome. These tumours typically progress slowly and have an extended disease course, and although they often present with metastases at diagnosis, surgical treatment has become increasingly important for their management. Surgery should include efforts to remove mesenteric metastases, which may cause severe long-term abdominal complications with typical fibrotic intestinal entrapment and small-bowel ischaemia due to compression of mesenteric vessels. Attempts should also be made to surgically remove or ablate liver metastases, since this may provide considerable palliation of the carcinoid syndrome. For patients with the carcinoid syndrome surgery is combined with continuous biotherapy with long-acting somatostatin analogues, which may alleviate symptoms and stabilize disease or slow progression. Favourable survival and appreciable quality of life can be expected with this combined treatment, even in patients with advanced midgut carcinoids.

Entities:  

Mesh:

Year:  2005        PMID: 16253896     DOI: 10.1016/j.bpg.2005.05.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  15 in total

Review 1.  Surgical treatment of gastrointestinal neuroendocrine tumors.

Authors:  Volker Fendrich; Detlef K Bartsch
Journal:  Langenbecks Arch Surg       Date:  2011-02-01       Impact factor: 3.445

2.  Partial abdominal evisceration and intestinal autotransplantation to resect a mesenteric carcinoid tumor.

Authors:  William H Kitchens; Nahel Elias; Lawrence S Blaszkowsky; A Benedict Cosimi; Martin Hertl
Journal:  World J Surg Oncol       Date:  2011-01-31       Impact factor: 2.754

3.  Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors.

Authors:  Christine S Landry; Heather Y Lin; Alexandria Phan; Chusilp Charnsangavej; Eddie K Abdalla; Thomas Aloia; J Nicolas Vauthey; Matthew H G Katz; James C Yao; Jason B Fleming
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

4.  Management of gastrointestinal carcinoid tumours - 10 years experience at a district general hospital.

Authors:  Shridhar S Dronamraju; Vickram B Joypaul
Journal:  J Gastrointest Oncol       Date:  2012-06

5.  Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.

Authors:  Olov Norlén; Peter Stålberg; Kjell Öberg; John Eriksson; Jakob Hedberg; Ola Hessman; Eva Tiensuu Janson; Per Hellman; Göran Åkerström
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 6.  The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.

Authors:  James R Howe; Kenneth Cardona; Douglas L Fraker; Electron Kebebew; Brian R Untch; Yi-Zarn Wang; Calvin H Law; Eric H Liu; Michelle K Kim; Yusuf Menda; Brian G Morse; Emily K Bergsland; Jonathan R Strosberg; Eric K Nakakura; Rodney F Pommier
Journal:  Pancreas       Date:  2017-07       Impact factor: 3.327

7.  The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours.

Authors:  L Bodei; J Mueller-Brand; R P Baum; M E Pavel; D Hörsch; M S O'Dorisio; T M O'Dorisio; T M O'Dorisiol; J R Howe; M Cremonesi; D J Kwekkeboom; John J Zaknun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05       Impact factor: 9.236

8.  Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs).

Authors:  Marybeth S Hughes; Saïd C Azoury; Yasmine Assadipour; David M Straughan; Apurva N Trivedi; Ramona M Lim; Grishma Joy; Mark T Voellinger; Derek M Tang; Aradhana M Venkatesan; Clara C Chen; Adeline Louie; Martha M Quezado; Joanne Forbes; Stephen A Wank
Journal:  Surgery       Date:  2015-10-09       Impact factor: 3.982

9.  Detection of neuroendocrine tumors of the small bowel by double balloon enteroscopy.

Authors:  Michael Bellutti; Lucia C Fry; Johannes Schmitt; Marcus Seemann; Silke Klose; Peter Malfertheiner; Klaus Mönkemüller
Journal:  Dig Dis Sci       Date:  2008-09-04       Impact factor: 3.199

10.  Health-Related Quality of Life After Surgery for Small Intestinal Neuroendocrine Tumours.

Authors:  Anna Caterina Milanetto; Erik Nordenström; Anna Sundlöv; Martin Almquist
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.